Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_1
2
50%
Ph not_applicable
2
50%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (50.0%)
N/A2 (50.0%)

Trials by Status

withdrawn125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Vitamin D Supplementation in Obesity and Weight Loss (3DD Study)

NCT01631292
withdrawnphase_1

High Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High Risk Pregnant Women

NCT03037593
completedphase_1

Effect of Vitamin D3 Supplementation in Pregnancy on Risk of Pre-eclampsia

NCT03101150
completednot_applicable

Effect of Vitamin D Supplementation on Oral Glucose Tolerance Among Obese Adolescents

NCT01856946

Clinical Trials (4)

Showing 4 of 4 trials
NCT01631292Not Applicable

Vitamin D Supplementation in Obesity and Weight Loss (3DD Study)

Completed
NCT03037593Phase 1

High Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High Risk Pregnant Women

Withdrawn
NCT03101150Phase 1

Effect of Vitamin D3 Supplementation in Pregnancy on Risk of Pre-eclampsia

Completed
NCT01856946Not Applicable

Effect of Vitamin D Supplementation on Oral Glucose Tolerance Among Obese Adolescents

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4